- Home
- JELD vs RLAY Comparison
JELD vs RLAY Comparison
Compare JELD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JELD
- RLAY
- Stock Information
- Founded
- JELD 1960
- RLAY 2015
- Country
- JELD United States
- RLAY United States
- Employees
- JELD N/A
- RLAY N/A
- Industry
- JELD Forest Products
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JELD Basic Materials
- RLAY Health Care
- Exchange
- JELD Nasdaq
- RLAY Nasdaq
- Market Cap
- JELD 540.5M
- RLAY 490.3M
- IPO Year
- JELD 2017
- RLAY 2020
- Fundamental
- Price
- JELD $3.64
- RLAY $3.00
- Analyst Decision
- JELD Hold
- RLAY Strong Buy
- Analyst Count
- JELD 8
- RLAY 11
- Target Price
- JELD $7.34
- RLAY $18.40
- AVG Volume (30 Days)
- JELD 2.4M
- RLAY 2.2M
- Earning Date
- JELD 05-05-2025
- RLAY 05-05-2025
- Dividend Yield
- JELD N/A
- RLAY N/A
- EPS Growth
- JELD N/A
- RLAY N/A
- EPS
- JELD N/A
- RLAY N/A
- Revenue
- JELD $3,592,472,000.00
- RLAY $7,679,000.00
- Revenue This Year
- JELD N/A
- RLAY N/A
- Revenue Next Year
- JELD $3.49
- RLAY $169.23
- P/E Ratio
- JELD N/A
- RLAY N/A
- Revenue Growth
- JELD N/A
- RLAY N/A
- 52 Week Low
- JELD $3.27
- RLAY $1.78
- 52 Week High
- JELD $17.70
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- JELD 36.85
- RLAY 51.78
- Support Level
- JELD $3.27
- RLAY $2.75
- Resistance Level
- JELD $4.10
- RLAY $3.10
- Average True Range (ATR)
- JELD 0.22
- RLAY 0.20
- MACD
- JELD 0.01
- RLAY 0.01
- Stochastic Oscillator
- JELD 27.76
- RLAY 54.10
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).